drugset / Trial / NCT05779657

Combined Ketamine and Midazolam for Generalized Convulsive Status Epilepticus

NCT05779657

Phase 2/3 Completed 144 enrolled Sohag University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Generalized convulsive status epilepticus (GCSE) is a common neurological emergency in children. Benzodiazepines are the recommended first line antiseizure medication (ASMs), but they fail to control seizures in a third of cases. Combination of benzodiazepines with another ASM that has a different mechanism of action may be a promising option for faster control of GCSE. In this study, the investigators aim to evaluate the efficacy and safety of ketamine plus midazolam versus midazolam alone as first-line therapy of pediatric GCSE.

Timeline

Start
2023-03-21
Primary completion
2024-08-26
Completion
2024-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 2 mg/kg Intravenous
Background Midazolam Small molecule 0.2 mg/kg Intravenous